Keyphrases
Co-driver
100%
Mutant p53
100%
Guide RNA (gRNA)
33%
RNA Sequencing (RNA-seq)
28%
Chromatin Immunoprecipitation (ChIP)
28%
Functional Validation
23%
Triple-negative Breast Cancer
23%
P53 mutant
23%
Multiplicity of Infection
19%
Mutant p53 Protein
19%
PTEN Deletion
14%
Plasmid
14%
TP53 mutation
14%
Driver mutations
14%
Tumor Protein p53 (TP53)
14%
Mutant Protein
14%
Next-generation Sequencing
9%
Co-mutation
9%
Invasiveness
9%
Screening Approach
9%
Expression Level
9%
Amplicon
9%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
9%
Cancer Progression
9%
Biochemistry, Genetics and Molecular Biology
P53
100%
RNA Sequencing
27%
CRISPR
13%
Mutant Protein
10%
Plasmid
10%
Amplicon
6%
Western Blot
6%
Tumor Suppressor Protein
6%
Tumor Progression
6%
Mouse
6%
Polymerase Chain Reaction
6%